Antiviral drug-resistant HBV: Standardiz
โ
Anna S. Lok; Fabien Zoulim; Stephen Locarnini; Angeline Bartholomeusz; Marc G. G
๐
Article
๐
2007
๐
John Wiley and Sons
๐
English
โ 231 KB
Substantial advances have been made in the treatment of chronic hepatitis B in the past decade. Approved treatments for chronic hepatitis B include 2 formulations of interferon and 4 nucleos(t)ide analogues (NAs). Sustained viral suppression is rarely achieved after withdrawal of a 48-week course of